Table 1.
Cell Type/Organ | Mouse/ Human |
Mutation/Gene Deficiency | Functional Effects | Reference |
---|---|---|---|---|
Single positive thymocytes | Mouse | Adar1 deletion in CD4+ T cells | Impaired T cell maturation, excessive ISG expression, defective TCR signaling, induction of autoimmunity (spontaneous colitis) | [54] |
Primary CD4+ T lymphocytes | Human | Adar1-deficient AGS patients | Upregulated ISG expression, resistance to HIV-1 infection | [7,56] |
mTECs | Mouse | None | Demonstration of high rates of editing events, acquisition of self-tolerance against edited-self, prevention of autoimmunity | [57] |
B lymphocytes | Mouse | Adar1 deletion in CD19+ B cells | Impaired B cell maturation, reduced numbers of peripheral blood and splenic B cells, enhanced excessive ISG expression and apoptosis | [9] |
Primary macrophages | Human | siRNA ADAR1 silencing | Enhanced production of IFN-I, chemokines and cytokines, inhibition of HIV-1 infection in bystander cells | [59] |
DCs | Mouse | Adar1 deletion in CD11c+ cells | Peripheral systemic loss of CD103+/CD8+ DCs, reduced number and dysfunction of AM, loss of RNA editing in AM | [8] |
Abbreviations: mTECs, medullary thymic epithelial cells; DCs, dendritic cells; AM, alveolar macrophages.